ArticleEMBO molecular medicine2023

mAb therapy controls CNS-resident lyssavirus infection via a CD4 T cell-dependent mechanism.

Kate E Mastraccio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.